Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $1.9 Million - $3.19 Million
1,697,539 Added 5.66%
31,697,539 $35.8 Million
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $4.35 Million - $8.85 Million
3,000,000 Added 11.11%
30,000,000 $45.6 Million
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $1.36 Million - $2.19 Million
675,000 Added 2.56%
27,000,000 $64.8 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $8 Million - $12.8 Million
4,083,583 Added 18.36%
26,325,000 $54 Million
Q2 2022

Aug 12, 2022

BUY
$1.3 - $2.64 $10.7 Million - $21.8 Million
8,242,926 Added 58.88%
22,241,417 $43.1 Million
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $32.9 Million - $48.6 Million
13,998,491 New
13,998,491 $34.4 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.